Tabo-tabo, Petra A.

HRN: 25-11-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
COTRIMOXAZOLE 960MG (TAB)
06/22/2026
06/28/2026
PO
960mg Tab
MWF
CML; Prophylaxis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: